Omada Health (OMDA) CEO Sean Duffy Sells Shares

What Happened
Sean Duffy, CEO of Omada Health, reported open‑market sales totaling 14,960 shares on September 10, 2026. The filing shows two reported lots: 13,560 shares at a weighted‑average price of $21.80 for $295,569, and 1,400 shares at a weighted‑average price of $22.59 for $31,628 — combined proceeds ≈ $327,197. These were sales (not purchases).

Key Details

• Transaction date: 2026‑09‑10; Filing date: 2026‑09‑14 (filed 4 days after the trades; Form 4s are generally due within two business days, so this appears outside the usual window).
• Reported prices (weighted averages): $21.80 (13,560 shares) and $22.59 (1,400 shares).
• Combined shares sold: 14,960; combined proceeds ≈ $327,197.
• Shares owned after transaction: Not specified in this Form 4.
• Footnotes of note:
  • F1: Trades executed under a 10b5‑1 trading plan adopted March 13, 2026 (prearranged plan).
  • F2/F3: Each reported lot was executed as multiple trades at price ranges (F2: $21.38–$22.325; F3: $22.41–$22.77); weighted averages are reported and detailed trade data can be provided on request.
  • F4: Some holdings are held in family trusts for beneficiaries; the reporting person disclaims beneficial ownership of those trust shares except to the extent of any pecuniary interest.

Context
These were planned sales under a 10b5‑1 arrangement, which typically indicate preauthorized, rule‑compliant dispositions rather than ad‑hoc decisions; sales are often routine and less informative about management’s private view of the company than purchases.